Pure Global
NCT05415852

Lasers in Onychomycosis

Comparison Between Different Types of LASER in the Treatment of Onychomycosis, a Randomized Controlled Trial
Cairo University·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Onychomycosis
Drug/Device/Intervention
Laser
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Cairo University
Timeline & enrollment
Phase
N/A
Start date
Jun 25, 2022
End date
Sep 15, 2022
Enrollment
40 participants
Primary outcome

Onychomycosis severity index

Summary

Onychomycosis is the most common nail disease, representing more than 50% of all
 onychopathies. Future studies on the absorption spectra of dermatophyte fungi will be needed
 to develop lasers that effectively exploit absorption differences in fungi and dermal tissue.

ICD-10 classifications
OnychogryphosisChromomycosis, unspecifiedOnycholysisActinomycosisBlastomycosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05415852
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05415852 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairo University and is currently Not yet recruiting. The study focuses on Onychomycosis. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.